Duration of antibiotics in kidney transplant recipients with pyelonephritis: Current practice, research gaps, and future research

Affiliations

¹ Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
² AP-HP, Infectious Diseases Unit, Saint-Louis Hospital, Paris, France.

Editorial

Julien Coussement et al. Transpl Infect Dis. 2023 Feb.

. 2023 Feb;25(1):e13997.

doi: 10.1111/tid.13997. Epub 2022 Dec 10.

¹ Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
² AP-HP, Infectious Diseases Unit, Saint-Louis Hospital, Paris, France.

No abstract available

References

1. van Delden C, Stampf S, Hirsch HH, et al. Burden and timeline of infectious diseases in the first year after solid organ transplantation in the Swiss Transplant Cohort Study. Clin Infect Dis. 2020;71(7):e159-e169.
1. Coussement J, Kaminski H, Scemla A, Manuel O. Asymptomatic bacteriuria and urinary tract infections in kidney transplant recipients. Curr Opin Infect Dis. 2020;33(6):419-425.
1. Imlay H, Laundy NC, Forrest GN, Slavin MA. Shorter antibiotic courses in the immunocompromised: the impossible dream? Clin Microbiol Infect. 2022. Aug 19;S1198-743X(22)00423-2. https://doi.org/10.1016/j.cmi.2022.08.007. Online ahead of print.
1. Goldman JD, Julian K, Practice ASTIDCo. Urinary tract infections in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13507.
1. The SHORTCUT trial: efficacy of 7 days versus 14 days of antibiotic therapy for acute pyelonephritis in kidney transplant recipients, a multicentre randomized non-inferiority trial (SHORTCUT). ClinicalTrials.gov Identifier: NCT05597540 (not yet recruiting). Available at: https://clinicaltrials.gov/ct2/show/NCT05597540 (6 December 2022, date last accessed).